Mice Model Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (CRISPR Knockout, Random Insertions, Large and Targeted Insertions, ES Cell Modification (Homologous Recombination), Others), By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research And Manufacturing Organizations), By Region, By Competition, 2019-2029F

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Forecast Period

2025-2029

Market Size (2023)

USD 1.22 Billion

Market Size (2029)

USD 2.17 Billion

CAGR (2024-2029)

10.23%

Fastest Growing Segment

CRISPR Knockout

Largest Market

North America

Market Overview

Global Mice Model Technologies Market was valued at USD 1.22 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 10.23% through 2029. The mice model technology market is experiencing growth propelled by increased investments in research and development within the pharmaceutical & biotechnology sector. Additionally, the utilization of mice models for personalized drug production is contributing to market expansion. The rising demand for mice models in the production of monoclonal antibodies further fuels market growth. However, the continuous discovery of substitute approaches for animal studies may restrain the global mice model technologies market during the forecast period.


Key Market Drivers

Rising Demand for Personalized Medicine

The growing demand for personalized medicine is expected to drive significant growth in the Global Mice Model Technologies Market. As the healthcare sector moves towards more personalized treatment approaches, mice models become crucial for preclinical research and drug development. These genetically engineered models, designed to mimic human conditions, enable researchers to gain deeper insights into disease mechanisms and identify targeted therapies. In the realm of personalized medicine, which tailors treatment plans based on an individual's genetic profile, sophisticated research tools like mice models are essential. The increasing adoption of precision medicine strategies fuels the demand for genetically modified mice, facilitating intricate studies on the efficacy and safety of new therapeutics. Moreover, the pharmaceutical and biotechnology sectors increasingly rely on mice models to streamline drug discovery processes, improving the efficiency of bringing new drugs to market. With the rising momentum towards personalized healthcare, the Global Mice Model Technologies Market is poised for substantial growth, driven by the indispensable role these models play in advancing the understanding and development of personalized medicine.

Growing Focus on Drug Discovery and Development

The growing emphasis on drug discovery and development is expected to drive the expansion of the Global Mice Model Technologies Market. In the dynamic pharmaceutical and biotechnology industries, mice models serve as critical assets for accelerating the drug development process. Their genetic resemblance to humans enables researchers to simulate and analyze human diseases, providing crucial insights into the efficacy and safety of potential drug candidates. The increasing demand for innovative therapeutics, along with the necessity for rapid and cost-effective drug discovery, underscores the indispensable role of mice models. Genetically modified mice facilitate the study of disease mechanisms, aiding in the identification of promising drug targets and the evaluation of new compounds. The efficiency gains achieved through mice models in preclinical research significantly contribute to expediting the overall drug development process. As the global healthcare industry intensifies its efforts to advance treatment modalities, the reliance on mice models for comprehensive preclinical studies becomes paramount. Consequently, the Global Mice Model Technologies Market is poised for substantial growth, driven by the pivotal role these models play in enhancing the efficiency and success rates of drug discovery and development initiatives.

Advancements in Genetic Engineering Techniques

The surge in advancements in genetic engineering techniques is set to drive the growth of the Global Mice Model Technologies Market. As state-of-the-art genetic engineering tools evolve, researchers gain unprecedented precision and efficiency in modifying mouse genomes for scientific investigations. This progress enables the creation of more sophisticated and relevant mice models that closely mimic human physiological conditions, proving invaluable in pharmaceutical and biotechnological research. Cutting-edge techniques like CRISPR-Cas9 have revolutionized the precision and speed with which genetic modifications can be introduced into mice, facilitating the development of highly targeted models for specific diseases. The ability to replicate human genetic mutations in mice enhances the translatability of research findings to human applications, bolstering the reliability of preclinical studies in drug development. The scalability and cost-effectiveness of these advancements further contribute to their widespread adoption, making genetically engineered mice more accessible to a broader spectrum of researchers and industries. As genetic engineering techniques continue to progress, their pivotal role in tailoring mice models to meet the demands of intricate biomedical research positions the Global Mice Model Technologies Market for substantial growth, fostering innovation and accelerating breakthroughs in various therapeutic areas.

 

Download Sample Report

Key Market Challenges

Ethical Considerations and Animal Welfare Concerns

Ethical considerations and heightened animal welfare concerns present significant challenges that could impede the growth of the Global Mice Model Technologies Market. As societal awareness and ethical standards evolve, there is an increasing scrutiny on the use of animals in research, including mice models. Ethical considerations surrounding the humane treatment of animals and the potential for suffering during experimentation may lead to regulatory restrictions and public opposition, hindering the market's growth. Stricter regulations and ethical guidelines may necessitate more rigorous approval processes, delaying research timelines and increasing costs for companies involved in mice model technologies. Additionally, concerns about the moral implications of genetic modifications and the use of animals for scientific purposes may lead to a decline in social acceptance, impacting the industry's social license to operate. Organizations in the mice model sector must proactively address these ethical concerns, emphasizing transparency, responsible animal care practices, and adherence to stringent ethical guidelines. Failure to address these concerns may not only hinder market growth but also pose reputational risks for companies operating in this space. A delicate balance between scientific advancement and ethical responsibility is essential to navigate these challenges and sustain the long-term viability of the Global Mice Model Technologies Market.

High Costs and Resource Intensiveness

The growth of the Global Mice Model Technologies Market faces a notable hindrance due to the dual challenges of high costs and resource intensiveness associated with these advanced research tools. Establishing and maintaining colonies of genetically modified mice require significant financial investments in specialized facilities, housing, and veterinary care. The intricate nature of genetic engineering techniques and the demand for specific mouse models contribute to the resource-intensive nature of this research. The high upfront costs for creating and maintaining mice colonies, coupled with the ongoing expenses of skilled personnel and sophisticated equipment, may act as a deterrent for smaller research institutions and companies with limited financial resources. Moreover, the time-intensive nature of developing and characterizing genetically modified mice extends research timelines, further impacting overall operational efficiency. As the industry strives to balance scientific innovation with economic considerations, addressing cost and resource challenges becomes imperative for sustained market growth. Collaborative efforts, technological advancements aimed at cost reduction, and strategic resource optimization will be essential for mitigating these barriers. Failure to navigate the cost and resource intensiveness may impede widespread adoption and accessibility, limiting the potential expansion of the Global Mice Model Technologies Market.

Key Market Trends

Rapid Advancements in Genetic Engineering

The rapid advancements in genetic engineering constitute a pivotal driver propelling the growth of the Global Mice Model Technologies Market. Breakthroughs in techniques such as CRISPR-Cas9 have revolutionized the precision, speed, and cost-effectiveness of manipulating mouse genomes, facilitating the creation of highly sophisticated and disease-relevant models. This acceleration in genetic engineering capabilities enables researchers to replicate human genetic conditions in mice with unprecedented accuracy, enhancing the translatability of preclinical findings to human applications.

The agility afforded by these advancements enables quicker development of diverse mouse models tailored to specific research needs, particularly in the fields of pharmaceuticals and biotechnology. Researchers can now expedite the exploration of novel drug targets, study disease mechanisms more comprehensively, and streamline the drug development pipeline. As genetic engineering technologies continue to evolve, fostering an environment of innovation and efficiency, the Global Mice Model Technologies Market is poised for robust growth. The ability to engineer mouse genomes aligns rapidly and precisely with the demands of an increasingly dynamic biomedical research landscape, positioning these technologies as indispensable tools for accelerated advancements in therapeutic discovery and development.

Focus on Immunodeficient and Humanized Mice Models

The strategic focus on immunodeficient and humanized mice models is a driving force propelling the growth of the Global Mice Model Technologies Market. Immunodeficient mice, lacking a functional immune system, and humanized mice, genetically modified to express human genes or immune components, have become indispensable in preclinical research. These models play a crucial role in assessing the safety and efficacy of novel therapeutics, particularly in the context of human immune responses. Pharmaceutical and biotechnology industries are increasingly relying on immunodeficient and humanized mice models to conduct more accurate and predictive preclinical studies. The ability of these models to mimic human physiological conditions closely enhances the reliability of research outcomes, particularly in the development of immunotherapies, vaccines, and personalized medicine.

The heightened demand for these specialized mice models is a direct response to the growing complexity of drug development and the need for more clinically relevant research tools. As the healthcare industry intensifies its focus on precision medicine and targeted therapies, the Global Mice Model Technologies Market is poised for substantial growth, driven by the indispensable role that immunodeficient and humanized mice models play in advancing the understanding and development of cutting-edge biomedical solutions.

Segmental Insights

Technology Insights

Based on the Technology, the CRISPR Knockout technology segment is anticipated to witness substantial market growth throughout the forecast period. The ascent of CRISPR Knockout technology stands as a key driver propelling the growth of the Global Mice Model Technologies Market. CRISPR, an innovative genome editing tool, has revolutionized the precision and efficiency with which genetic modifications are introduced into mouse genomes. This breakthrough technology allows researchers to selectively "knock out" specific genes, creating genetically modified mice with targeted genetic alterations that mimic human diseases more accurately. The speed and cost-effectiveness of CRISPR Knockout technology have significantly accelerated the generation of customized mice models, reducing both research timelines and associated costs. The tool's versatility enables researchers to swiftly develop mouse models for a wide array of diseases, providing a robust platform for preclinical research in pharmaceuticals and biotechnology. As the demand for more sophisticated and disease-relevant mice models continues to grow, CRISPR Knockout technology emerges as a cornerstone in meeting these evolving research needs. Its transformative impact on genetic manipulation not only expedites drug development processes but also enhances the precision and predictive value of preclinical studies. Thus, the Global Mice Model Technologies Market is poised for substantial growth, driven by the unparalleled capabilities and efficiencies afforded by CRISPR Knockout technology in advancing biomedical research and therapeutic discovery.



Download Sample Report

Regional Insights

North America, specifically the Mice Model Technologies Market, dominated the market in 2023, primarily due to North America is poised to drive substantial growth in the Global Mice Model Technologies Market. North America's dominance in the global mice model technologies market is supported by robust infrastructure, well-established biotechnology and pharmaceutical industries, and extensive research and development activities. The presence of leading biotech and pharmaceutical companies, particularly in the United States, drives the demand for advanced mice models for drug discovery and development purposes. The region benefits from a progressive regulatory environment that encourages biomedical research, fostering innovation and the use of mice models in experiments. Additionally, North America's concentration of top-tier research institutions and academic centers contributes to the widespread adoption of cutting-edge mice model technologies. Collaborations between academia and industry stakeholders, alongside substantial investments in genetic engineering and CRISPR-Cas9 technologies, highlight North America's significant role in shaping the market landscape. With a growing focus on personalized medicine and precision therapeutics, the demand for specialized and genetically engineered mice models is expected to increase in the region.

Recent Development

  • In December 2023, Biocytogen Pharmaceuticals (Beijing) Co., Ltd announced that it had entered into an antibody evaluation and option agreement with Neurocrine Biosciences, Inc. The agreement granted Neurocrine Biosciences access to Biocytogen’s fully human antibodies against multiple specified targets, with an option to license selected antibodies for therapeutic product development, manufacturing, and commercialization for all uses worldwide. Additional targets could have been included under this agreement subject to mutual agreement. The antibodies were generated by Biocytogen’s proprietary RenMice® platforms. Under the terms of the agreement, if options were exercised, Biocytogen would have been entitled to option-exercise fees, development and commercialization milestone payments, as well as single-digit royalties on net sales for each selected target.

Key Market Players

  • Biocytogen LLC
  • Charles River Laboratories Inc.
  • Cyagen Biosciences
  • GemPharmatech Co Ltd.
  • genOway S.A.
  • Ingenious Targeting Laboratory Inc.
  • Merck KGaA.
  • Ozgene Pty Ltd.
  • Taconic Biosciences Inc.
  • Polygena AG

 By Technology

By End Users

By Region
  • CRISPR Knockout
  • Random Insertions
  • Large and Targeted Insertions
  • ES Cell Modification (Homologous Recombination)
  • Others
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Facilities
  • Contract Research and Manufacturing Organizations
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

 

Report Scope:

In this report, the Global Mice Model Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

·         Mice Model Technologies Market, By Technology:

o   CRISPR Knockout

o   Random Insertions

o   Large and Targeted Insertions

o   ES Cell Modification (Homologous Recombination)

o   Others

·         Mice Model Technologies Market, By End User:

o   Pharmaceutical Companies

o   Biotechnology Companies

o   Academic and Research Facilities

o   Contract Research and Manufacturing Organizations

·         Mice Model Technologies Market, By Region:

    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • France
      • United Kingdom
      • Italy
      • Germany
      • Spain
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Mice Model Technologies Market.

Available Customizations:

Global Mice Model Technologies market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

·         Detailed analysis and profiling of additional market players (up to five).

Global Mice Model Technologies Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.       Markets Covered

1.2.2.       Years Considered for Study

1.2.3.       Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Mice Model Technologies Market Outlook

5.1.  Market Size & Forecast

5.1.1.       By Value

5.2.  Market Share & Forecast

5.2.1.       By Technology (CRISPR Knockout, Random Insertions, Large and Targeted Insertions, ES Cell Modification (Homologous Recombination), Others)

5.2.2.       By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research And Manufacturing Organizations)

5.2.3.       By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

5.2.4.       By Company (2023)

5.3.  Market Map

5.3.1 By Technology

5.3.2 By End Users

5.3.3 By Region

6.    North America Mice Model Technologies Market Outlook

6.1.  Market Size & Forecast       

6.1.1.       By Value

6.2.  Market Share & Forecast

6.2.1.       By Technology (CRISPR Knockout, Random Insertions, Large, Targeted Insertions, ES Cell Modification (Homologous Recombination), Others)

6.2.2.       By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research And Manufacturing Organizations)

6.2.3.       By Country

6.3.  North America: Country Analysis

6.3.1.       United States Mice Model Technologies Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.           By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.           By Technology

6.3.1.2.2.           By End Users

6.3.2.       Canada Mice Model Technologies Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.           By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.           By Technology

6.3.2.2.2.           By End Users

6.3.3.       Mexico Mice Model Technologies Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.           By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.           By Technology

6.3.3.2.2.           By End Users

7.    Europe Mice Model Technologies Market Outlook

7.1.  Market Size & Forecast       

7.1.1.       By Value

7.2.  Market Share & Forecast

7.2.1.       By Technology (CRISPR Knockout, Random Insertions, Large, Targeted Insertions, ES Cell Modification (Homologous Recombination), Others)

7.2.2.       By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research and Manufacturing Organizations)

7.2.3.       By Country

7.3.  Europe: Country Analysis

7.3.1.       France Mice Model Technologies Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           By Technology

7.3.1.2.2.           By End Users

7.3.2.       Germany Mice Model Technologies Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           By Technology

7.3.2.2.2.           By End Users

7.3.3.       United Kingdom Mice Model Technologies Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           By Technology

7.3.3.2.2.           By End Users

7.3.4.       Italy Mice Model Technologies Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.           By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.           By Technology

7.3.4.2.2.           By End Users

7.3.5.       Spain Mice Model Technologies Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.           By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.           By Technology

7.3.5.2.2.           By End Users

8.    Asia-Pacific Mice Model Technologies Market Outlook

8.1.  Market Size & Forecast       

8.1.1.       By Value

8.2.  Market Share & Forecast

8.2.1.       By Technology (CRISPR Knockout, Random Insertions, Large, Targeted Insertions, ES Cell Modification (Homologous Recombination), Others)

8.2.2.       By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research and Manufacturing Organizations)

8.2.3.       By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.       China Mice Model Technologies Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           By Technology

8.3.1.2.2.           By End Users

8.3.2.       India Mice Model Technologies Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           By Technology

8.3.2.2.2.           By End Users

8.3.3.       Japan Mice Model Technologies Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           By Technology

8.3.3.2.2.           By End Users

8.3.4.       South Korea Mice Model Technologies Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.           By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.           By Technology

8.3.4.2.2.           By End Users

8.3.5.       Australia Mice Model Technologies Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.           By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.           By Technology

8.3.5.2.2.           By End Users

9.    South America Mice Model Technologies Market Outlook

9.1.  Market Size & Forecast       

9.1.1.       By Value

9.2.  Market Share & Forecast

9.2.1.       By Technology (CRISPR Knockout, Random Insertions, Large, Targeted Insertions, ES Cell Modification (Homologous Recombination), Others)

9.2.2.       By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research and Manufacturing Organizations)

9.2.3.       By Country

9.3.  South America: Country Analysis

9.3.1.       Brazil Mice Model Technologies Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           By Technology

9.3.1.2.2.           By End Users

9.3.2.       Argentina Mice Model Technologies Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           By Technology

9.3.2.2.2.           By End Users

9.3.3.       Colombia Mice Model Technologies Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           By Technology

9.3.3.2.2.           By End Users

10. Middle East and Africa Mice Model Technologies Market Outlook

10.1.             Market Size & Forecast        

10.1.1.     By Value

10.2.             Market Share & Forecast

10.2.1.     By Technology (CRISPR Knockout, Random Insertions, Large, Targeted Insertions, ES Cell Modification (Homologous Recombination), Others)

10.2.2.     By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research and Manufacturing Organizations)

10.2.3.     By Country

10.3.             MEA: Country Analysis

10.3.1.     South Africa Mice Model Technologies Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Technology

10.3.1.2.2.         By End Users

10.3.2.     Saudi Arabia Mice Model Technologies Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Technology

10.3.2.2.2.         By End Users

10.3.3.     UAE Mice Model Technologies Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Technology

10.3.3.2.2.         By End Users

11. Market Dynamics

11.1.             Drivers

11.2.             Challenges

12. Market Trends & Developments

12.1.             Recent Development

12.2.             Mergers & Acquisitions

12.3.             Product Launches

13. Global Mice Model Technologies Market: SWOT Analysis

14. Porter’s Five Forces Analysis

14.1.             Competition in the Industry

14.2.             Potential of New Entrants

14.3.             Power of Suppliers

14.4.             Power of Customers

14.5.             Threat of Substitute Technologies

15. Competitive Landscape

15.1.             Biocytogen LLC.

15.1.1.     Business Overview

15.1.2.     Product Offerings

15.1.3.     Recent Developments

15.1.4.     Financials (As Reported)

15.1.5.     Key Personnel

15.1.6.     SWOT Analysis

15.2.             Charles River Laboratories Inc.

15.3.             Cyagen Biosciences.

15.4.             GemPharmatech Co Ltd.

15.5.             genOway S.A.

15.6.             Ingenious Targeting Laboratory Inc.

15.7.             Merck KGaA.

15.8.             Ozgene Pty Ltd.

15.9.             Taconic Biosciences Inc.

15.10.          Polygena AG.

16.  Strategic Recommendations

17.   About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global Mice Model Technologies Market was estimated to be USD 1.22 Billion in 2023.

down-arrow

The CRISPR knockout segment demonstrated significant dominance in 2023, primarily due to impact of the target gene can be minimized without any of the adverse effects of drugs and the genome can be modified to determine the essential role of several endogenous variables in behavior.

down-arrow

North America emerged as the dominant market in 2023, Strategic collaborations between academia and industry players, coupled with significant investments in genetic engineering and CRISPR-Cas9 technologies.

down-arrow

Rising Demand for Personalized Medicine, Growing Focus on Drug Discovery and Development, Advancements in Genetic Engineering Techniques are the major drivers for the Global Mice Model Technologies Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Mice Model Technologies Market to Grow with a CAGR of 10.23% through 2029

Apr, 2024

Increasing utilization of mice s for personalized drug production are expected to drive the Global Mice Model Technologies Market growth in the forecast period, 2025-2029

Why Choose Us